Morgan Stanley lowered the firm’s price target on Gap (GAP) to $27 from $30 and keeps an Overweight rating on the shares. For the North American softlines retail group, the firm anticipates broad-based Q1 EPS upside is likely to be overshadowed by tariff-driven FY25 guidance reductions and withdrawals, the analyst tells investors in a sector earnings preview note. Q1 prints could “prove a negative catalyst for most Softlines Retail stocks,” with Bath & Body Works (BBWI) and Gap called out by the firm as “unique possible exceptions.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GAP:
- Victoria’s Secret price target lowered to $19 from $23 at Morgan Stanley
- Wells Fargo Downgrades Nike Stock (NKE) as “Turnaround Is Simply Taking Longer Than Hoped”
- Gap downgraded to Equal Weight from Overweight at Wells Fargo
- Gap price target lowered to $25 from $34 at Goldman Sachs
- Unusually active option classes on open April 14th